Biosymmetry Wilmington-Leland

Biosymmetry Wilmington-Leland operates under the clinical direction of Dr. Allen Holmes, a board-certified surgeon with credentials from the American Board of Plastic Surgery, the American College of Surgeons, and fellowship training recognized by the American Academy of Facial Plastic and Reconstructive Surgery. Located in Leland, North Carolina, the clinic integrates surgical expertise with regenerative medicine protocols to address hormone imbalances, metabolic dysfunction, sexual health concerns, and aesthetic optimization. Dr. Holmes applies his surgical background to patient assessment, ensuring that treatment plans account for anatomical precision and physiological response patterns rather than relying solely on symptom checklists.

The clinic offers PT-141 (bremelanotide) peptide therapy as part of its sexual health program, targeting melanocortin receptors to address hypoactive sexual desire and erectile function without relying on vascular mechanisms alone. This peptide is administered via subcutaneous injection and is typically prescribed for patients who have not responded adequately to PDE5 inhibitors or who present with central nervous system-mediated sexual dysfunction. Hormone therapy protocols at Biosymmetry Wilmington-Leland include bioidentical testosterone, estrogen, and progesterone replacement, with dosing adjusted based on serial lab work that tracks free and total hormone levels, SHBG, and metabolite ratios. Weight management programs combine GLP-1 receptor agonist medications with structured nutrition counseling that emphasizes protein intake, resistance training integration, and metabolic rate optimization rather than calorie restriction alone.

Dr. Holmes conducts in-person consultations that include comprehensive intake history, physical examination, and discussion of prior lab results or imaging studies. Initial visits typically involve ordering a hormone panel, metabolic markers including fasting insulin and lipid subfractions, and thyroid function tests to establish baseline physiology. Follow-up appointments are scheduled at intervals determined by treatment type—patients on testosterone replacement are generally seen every 8-12 weeks, while those initiating peptide therapy may require more frequent monitoring during the titration phase. The clinic's approach to hormone therapy includes cardiovascular risk stratification, with attention to blood pressure trends, hematocrit levels, and lipid panel changes that can accompany androgen replacement.

Patients at Biosymmetry Wilmington-Leland report improvements in energy levels, exercise recovery, and symptom resolution related to hormone deficiency, based on the clinic's Google reviews. The clinical team provides education on lifestyle factors that influence treatment outcomes, including sleep hygiene, resistance training frequency, and dietary protein distribution across meals. Medication management includes both prescription pharmaceuticals and nutraceutical supplementation when indicated by lab findings or clinical presentation. The clinic does not offer telehealth services, requiring all consultations and follow-ups to occur at the Leland location, which allows Dr. Holmes to perform physical examinations and assess treatment response through direct observation.

Biosymmetry Wilmington-Leland distinguishes itself through Dr. Holmes' surgical training, which informs his understanding of tissue response, wound healing, and the systemic effects of hormonal interventions on connective tissue and vascular health. The clinic's aesthetic services are integrated with its hormone and metabolic programs, recognizing that skin quality, body composition, and facial volume are influenced by endocrine status and nutritional sufficiency. Patients seeking peptide therapy or hormone optimization in the Leland and greater Wilmington area have access to a provider whose board certifications in plastic surgery and facial reconstruction provide a depth of anatomical and physiological knowledge that extends beyond standard hormone replacement protocols.